glp-1 ra cardiovascular benefits Frontiers GLP-1 receptor agonist therapy for

A proof-of-concept trial investigating metformin as an add-on treatment for mild or moderate SLE demonstrated that metformin down-regulated the NETs mtDNA-PDC-IFN pathway, leading to clinical improvement of SLE and reduced its reliance on prednisolone (133)

doi: 10.14309/00000434-201810001-00983 45

What about a GIP

Weight-Loss Injections work by mimicking a natural hormone in the body called glucagon-like peptide 1, or GLP-1

6 Application of GLP-1RA in tumors As a hypoglycemic agent, GLP-1RA has not been applied to the treatment of oncologic diseases alone, but studies on the correlation between GLP-1RA and tumors can also guide the use of drugs in patients with related tumor diseases